Lanthanum Carbonate Modulates Inflammatory Profile in Hemodialysis Patients: Relationship with Fibroblast Growth Factor-23
Elevated fibroblast growth factor 23 (FGF-23) is independently associated with increased inflammatory markers in chronic kidney disease. Lanthanum carbonate (LaCa) reduces FGF-23. We studied the effects of LaCa on inflammatory profile of hemodialysis patients, and the relationship with changes in FG...
Main Authors: | J.F. Navarro-González, J. Donate-Correa, M. Muros, P. García-García, M.A. Getino, J. García-Pérez, C. Mora-Fernández |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-01-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1301100108 |
Similar Items
-
Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
by: Javier Donate-Correa, et al.
Published: (2021-06-01) -
Inflammatory Cytokines in Diabetic Nephropathy
by: Javier Donate-Correa, et al.
Published: (2015-01-01) -
Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India
by: U Anandh, et al.
Published: (2017-01-01) -
Role of sclerostin, fibroblast growth factor-23, and Klotho in hemodialysis patients
by: Azza A I. Elmenyawi, et al.
Published: (2019-01-01) -
Intact Fibroblast Growth Factor 23 and Peripheral Vascular Complications in Patients on Hemodialysis
by: Melahat, et al.
Published: (2020-03-01)